Novartis Investigative Site

Humenné

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease (COPD)

Studies at this site

• A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD) — Completed